C178H166F2N24O14 — CID 158217360
2-[4-(1-adamantylcarbamoyl)phenyl]-N-cyclohexyl-3H-benzimidazole-5-carboxamide;N-(4-fluorophenyl)-2-[4-[(4-fluorophenyl)carbamoyl]phenyl]-3H-benzimidazole-5-carboxamide;N-(4-methoxyphenyl)-2-[4-[(4-methoxyphenyl)carbamoyl]phenyl]-3H-benzimidazole-5-carboxamide;N-(4-methylcyclohexyl)-2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazole-5-carboxamide;N-(4-methylphenyl)-2-[4-[(4-methylphenyl)carbamoyl]phenyl]-3H-benzimidazole-5-carboxamide;N-(2-phenylcyclopropyl)-2-[4-[(2-phenylcyclopropyl)carbamoyl]phenyl]-3H-benzimidazole-5-carboxamide (PubChem CID 158217360) has the molecular formula C178H166F2N24O14 and a molecular weight of 2903.44 g/mol. Its IUPAC name is 2-[4-(1-adamantylcarbamoyl)phenyl]-N-cyclohexyl-3H-benzimidazole-5-carboxamide;N-(4-fluorophenyl)-2-[4-[(4-fluorophenyl)carbamoyl]phenyl]-3H-benzimidazole-5-carboxamide;N-(4-methoxyphenyl)-2-[4-[(4-methoxyphenyl)carbamoyl]phenyl]-3H-benzimidazole-5-carboxamide;N-(4-methylcyclohexyl)-2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazole-5-carboxamide;N-(4-methylphenyl)-2-[4-[(4-methylphenyl)carbamoyl]phenyl]-3H-benzimidazole-5-carboxamide;N-(2-phenylcyclopropyl)-2-[4-[(2-phenylcyclopropyl)carbamoyl]phenyl]-3H-benzimidazole-5-carboxamide.
| Compound Name | 2-[4-(1-adamantylcarbamoyl)phenyl]-N-cyclohexyl-3H-benzimidazole-5-carboxamide;N-(4-fluorophenyl)-2-[4-[(4-fluorophenyl)carbamoyl]phenyl]-3H-benzimidazole-5-carboxamide;N-(4-methoxyphenyl)-2-[4-[(4-methoxyphenyl)carbamoyl]phenyl]-3H-benzimidazole-5-carboxamide;N-(4-methylcyclohexyl)-2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazole-5-carboxamide;N-(4-methylphenyl)-2-[4-[(4-methylphenyl)carbamoyl]phenyl]-3H-benzimidazole-5-carboxamide;N-(2-phenylcyclopropyl)-2-[4-[(2-phenylcyclopropyl)carbamoyl]phenyl]-3H-benzimidazole-5-carboxamide |
|---|---|
| PubChem CID | 158217360 |
| Molecular Formula | C178H166F2N24O14 |
| Molecular Weight | 2903.44 g/mol |
| Exact Mass | 2901.30 |
| IUPAC Name | 2-[4-(1-adamantylcarbamoyl)phenyl]-N-cyclohexyl-3H-benzimidazole-5-carboxamide;N-(4-fluorophenyl)-2-[4-[(4-fluorophenyl)carbamoyl]phenyl]-3H-benzimidazole-5-carboxamide;N-(4-methoxyphenyl)-2-[4-[(4-methoxyphenyl)carbamoyl]phenyl]-3H-benzimidazole-5-carboxamide;N-(4-methylcyclohexyl)-2-[4-[(4-methylcyclohexyl)carbamoyl]phenyl]-3H-benzimidazole-5-carboxamide;N-(4-methylphenyl)-2-[4-[(4-methylphenyl)carbamoyl]phenyl]-3H-benzimidazole-5-carboxamide;N-(2-phenylcyclopropyl)-2-[4-[(2-phenylcyclopropyl)carbamoyl]phenyl]-3H-benzimidazole-5-carboxamide |
| SMILES | CC1CCC(NC(=O)c2ccc(-c3nc4ccc(C(=O)NC5CCC(C)CC5)cc4[nH]3)cc2)CC1.COc1ccc(NC(=O)c2ccc(-c3nc4ccc(C(=O)Nc5ccc(OC)cc5)cc4[nH]3)cc2)cc1.Cc1ccc(NC(=O)c2ccc(-c3nc4ccc(C(=O)Nc5ccc(C)cc5)cc4[nH]3)cc2)cc1.O=C(NC1CC1c1ccccc1)c1ccc(-c2nc3ccc(C(=O)NC4CC4c4ccccc4)cc3[nH]2)cc1.O=C(NC1CCCCC1)c1ccc2nc(-c3ccc(C(=O)NC45CC6CC(CC(C6)C4)C5)cc3)[nH]c2c1.O=C(Nc1ccc(F)cc1)c1ccc(-c2nc3ccc(C(=O)Nc4ccc(F)cc4)cc3[nH]2)cc1 |
| InChI | InChI=1S/C33H28N4O2.C31H36N4O2.C29H24N4O4.C29H36N4O2.C29H24N4O2.C27H18F2N4O2/c38-32(36-28-18-25(28)20-7-3-1-4-8-20)23-13-11-22(12-14-23)31-34-27-16-15-24(17-30(27)35-31)33(39)37-29-19-26(29)21-9-5-2-6-10-21;36-29(32-25-4-2-1-3-5-25)24-10-11-26-27(15-24)34-28(33-26)22-6-8-23(9-7-22)30(37)35-31-16-19-12-20(17-31)14-21(13-19)18-31;1-36-23-12-8-21(9-13-23)30-28(34)19-5-3-18(4-6-19)27-32-25-16-7-20(17-26(25)33-27)29(35)31-22-10-14-24(37-2)15-11-22;2*1-18-3-12-23(13-4-18)30-28(34)21-9-7-20(8-10-21)27-32-25-16-11-22(17-26(25)33-27)29(35)31-24-14-5-19(2)6-15-24;28-19-6-10-21(11-7-19)30-26(34)17-3-1-16(2-4-17)25-32-23-14-5-18(15-24(23)33-25)27(35)31-22-12-8-20(29)9-13-22/h1-17,25-26,28-29H,18-19H2,(H,34,35)(H,36,38)(H,37,39);6-11,15,19-21,25H,1-5,12-14,16-18H2,(H,32,36)(H,33,34)(H,35,37);3-17H,1-2H3,(H,30,34)(H,31,35)(H,32,33);7-11,16-19,23-24H,3-6,12-15H2,1-2H3,(H,30,34)(H,31,35)(H,32,33);3-17H,1-2H3,(H,30,34)(H,31,35)(H,32,33);1-15H,(H,30,34)(H,31,35)(H,32,33) |
| InChIKey | GCVAOVGDJSHSNP-UHFFFAOYSA-N |
| XLogP | 35.76 |
| TPSA | 539.74 Ų |
| H-Bond Donors | 18 |
| H-Bond Acceptors | 20 |
| Rotatable Bonds | 34 |
| Heavy Atoms | 218 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2903.44 |
| LogP ≤ 5 | 35.76 |
| H-Bond Donors ≤ 5 | 18 |
| H-Bond Acceptors ≤ 10 | 20 |